Market Tracker

02/22 3:50am ET

Arbutus Biopharma Corp (NASDAQ:ABUS)

5.25
Delayed Data
As of Feb 21
 -0.25 / -4.55%
Today’s Change
2.55
Today|||52-Week Range
8.25
+3.96%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close5.50
Today’s open5.50
Day’s range5.20 - 5.60
Volume116,159
Average volume (3 months)238,765
Market cap$302.8M
Data as of 4:00pm ET, 02/21/2018

Growth & Valuation

Earnings growth (last year)-440.30%
Earnings growth (this year)+81.85%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-94.01%
P/E ratioNM
Price/Sales87.21
Price/Book1.49

Competitors

 Today’s
change
Today’s
% change
OVIDOvid Therapeutics In...-0.20-2.84%
CPRXCatalyst Pharmaceuti...-0.09-2.78%
DRRXDURECT Corp+0.03+2.75%
STMLStemline Therapeutic...+0.75+4.75%
Data as of 4:15pm ET, 02/21/2018

Financials

Next reporting dateMarch 20, 2018
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$1.5M
Annual profit (last year)-$384.2M
Net profit margin-25,765.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer &
Executive Vice President
Bruce G. Cousins
Corporate headquarters
Burnaby, British Columbia

Forecasts